Thalidomide Therapy and Deep Venous Thrombosis in Multiple Myeloma
- 1 December 2005
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 80 (12) , 1549-1551
- https://doi.org/10.4065/80.12.1549
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Multiple Myeloma: Diagnosis and TreatmentMayo Clinic Proceedings, 2005
- Multiple myeloma: the death of VAD as initial therapyBlood, 2005
- Five decades of therapy for multiple myeloma: a paradigm for therapeutic modelsLeukemia, 2005
- Multiple MyelomaNew England Journal of Medicine, 2004
- Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological ActivityMayo Clinic Proceedings, 2004
- Thalidomide: Current Role in the Treatment of Non-Plasma Cell MalignanciesJournal of Clinical Oncology, 2004
- Treatment of Plasma Cell Dyscrasias With Thalidomide and Its DerivativesJournal of Clinical Oncology, 2003
- Multiple Myeloma: How Far Have We Come?Mayo Clinic Proceedings, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999